Annual Shareholders Equity
$26.77 M
+$8.66 M+47.80%
31 December 2023
Summary:
Tempest Therapeutics annual stockholders equity is currently $26.77 million, with the most recent change of +$8.66 million (+47.80%) on 31 December 2023. During the last 3 years, it has risen by +$95.56 million (+138.91%). TPST annual shareholders equity is now -25.89% below its all-time high of $36.12 million, reached on 31 December 2021.TPST Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$11.46 M
-$5.48 M-32.36%
30 September 2024
Summary:
Tempest Therapeutics quarterly stockholders equity is currently $11.46 million, with the most recent change of -$5.48 million (-32.36%) on 30 September 2024. Over the past year, it has increased by +$12.65 million (+1062.77%). TPST quarterly shareholders equity is now -76.19% below its all-time high of $48.11 million, reached on 30 June 2021.TPST Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.8% | +1062.8% |
| 3 y3 years | +138.9% | -73.7% |
| 5 y5 years | - | - |
TPST Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.9% | +138.9% | -73.7% | +1062.8% |
| 5 y | 5 years | -25.9% | +138.9% | -76.2% | +116.7% |
| alltime | all time | -25.9% | +138.9% | -76.2% | +116.7% |
Tempest Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.46 M(-32.4%) |
| June 2024 | - | $16.94 M(-17.9%) |
| Mar 2024 | - | $20.63 M(-22.9%) |
| Dec 2023 | $26.77 M(+47.8%) | $26.77 M(-2349.4%) |
| Sept 2023 | - | -$1.19 M(-123.7%) |
| June 2023 | - | $5.01 M(-54.3%) |
| Mar 2023 | - | $10.96 M(-39.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $18.11 M(-49.9%) | $18.11 M(-32.4%) |
| Sept 2022 | - | $26.77 M(-23.4%) |
| June 2022 | - | $34.93 M(+19.0%) |
| Mar 2022 | - | $29.36 M(-18.7%) |
| Dec 2021 | $36.12 M(-152.5%) | $36.12 M(-17.0%) |
| Sept 2021 | - | $43.54 M(-9.5%) |
| June 2021 | - | $48.11 M(-169.9%) |
| Dec 2020 | -$68.79 M | -$68.79 M |
FAQ
- What is Tempest Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Tempest Therapeutics?
- What is Tempest Therapeutics annual shareholders equity year-on-year change?
- What is Tempest Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly shareholders equity year-on-year change?
What is Tempest Therapeutics annual stockholders equity?
The current annual shareholders equity of TPST is $26.77 M
What is the all time high annual shareholders equity for Tempest Therapeutics?
Tempest Therapeutics all-time high annual stockholders equity is $36.12 M
What is Tempest Therapeutics annual shareholders equity year-on-year change?
Over the past year, TPST annual stockholders equity has changed by +$8.66 M (+47.80%)
What is Tempest Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TPST is $11.46 M
What is the all time high quarterly shareholders equity for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly stockholders equity is $48.11 M
What is Tempest Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TPST quarterly stockholders equity has changed by +$12.65 M (+1062.77%)